首页> 外文期刊>Trials >Open reduction and internal fixation versus casting for highly comminuted and intra-articular fractures of the distal radius (ORCHID): protocol for a randomized clinical multi-center trial
【24h】

Open reduction and internal fixation versus casting for highly comminuted and intra-articular fractures of the distal radius (ORCHID): protocol for a randomized clinical multi-center trial

机译:reduction骨远端粉碎性骨折和关节内骨折(ORCHID)的切开复位内固定与铸造相比:一项随机临床多中心试验的方案

获取原文
获取外文期刊封面目录资料

摘要

Background Fractures of the distal radius represent the most common fracture in elderly patients, and often indicate the onset of symptomatic osteoporosis. A variety of treatment options is available, including closed reduction and plaster casting, K-wire-stabilization, external fixation and open reduction and internal fixation (ORIF) with volar locked plating. The latter is widely promoted by clinicians and hardware manufacturers. Closed reduction and cast stabilization for six weeks is a simple, convenient, and ubiquitously available intervention. In contrast, ORIF requires hospitalization, but allows for functional rehabilitation. Given the lack of randomized controlled trials, it remains unclear whether ORIF leads to better functional outcomes one year after injury than closed reduction and casting. Methods/Design ORCHID (Open reduction and internal fixation versus casting for highly comminuted intra-articular fractures of the distal radius) is a pragmatic, randomized, multi-center, clinical trial with two parallel treatment arms. It is planned to include 504 patients in 15 participating centers throughout Germany over a three-year period. Patients are allocated by a central web-based randomization tool. The primary objective is to determine differences in the Short Form 36 (SF-36) Physical Component Score (PCS) between volar locked plating and closed reduction and casting of intraarticular, comminuted distal radius fractures in patients > 65 years of age one year after the fracture. Secondary outcomes include differences in other SF-36 dimensions, the EuroQol-5D questionnaire, the Disability of the Arm, Shoulder, and Hand (DASH) instrument. Also, the range of motion in the affected wrist, activities of daily living, complications (including secondary ORIF and revision surgery), as well as serious adverse events will be assessed. Data obtained during the trial will be used for later health-economic evaluations. The trial architecture involves a central statistical unit, an independent monitoring institute, and a data safety monitoring board. Following approval by the institutional review boards of all participating centers, conduct and reporting will strictly adhere to national and international rules, regulations, and recommendations (e.g., Good Clinical Practice, data safety laws, and EQUATOR/CONSORT proposals) Discussion To our knowledge, ORCHID is the first multicenter RCT designed to assess quality of life and functional outcomes following operative treatment compared to conservative treatment of complex, intra-articular fractures of the distal radius in elderly patients. The results are expected to influence future treatment recommendations and policies on an international level. Trial registration ISRCTN: ISRCTN76120052 Registration date: 31.07.2008; Randomization of first patient: 15.09.2008
机译:背景radius骨远端骨折是老年患者中最常见的骨折,并且通常表明有症状的骨质疏松症的发作。提供多种治疗选择,包括闭合复位和石膏铸造,K线稳定,外固定和开复位和内固定(手掌锁定钢板)。后者由临床医生和硬件制造商广泛推广。密闭还原和铸件稳定六周是一种简单,方便且无所不在的干预措施。相反,ORIF需要住院治疗,但可以进行功能康复。鉴于缺乏随机对照试验,目前尚不清楚ORIF是否比闭合复位和石膏法在损伤后一年能导致更好的功能结局。方法/设计ORCHID(切开复位内固定术与远距离粉碎性radius骨远端骨折的内固定术)是一种实用的,随机的,多中心,带有两个平行治疗臂的临床试验。计划在三年内在德国15个参与中心的504名患者中进行治疗。通过基于网络的中央随机化工具分配患者。主要目的是确定在大于65岁年龄的患者中,掌侧锁定钢板与闭合复位和铸造的关节内粉碎性distal骨远端骨折之间的简短表格36(SF-36)物理成分评分(PCS)之间的差异。断裂。次要结果包括其他SF-36尺寸,EuroQol-5D问卷,手臂,肩膀和手部残疾(DASH)仪器的差异。此外,还将评估患腕的活动范围,日常生活活动,并发症(包括继发的ORIF和翻修手术)以及严重的不良事件。试验期间获得的数据将用于以后的健康经济评估。该试验体系结构包括一个中央统计部门,一个独立的监测机构和一个数据安全监测委员会。在所有参与中心的机构审查委员会批准后,行为和报告将严格遵守国家和国际规则,规定和建议(例如,良好的临床实践,数据安全法律和EQUATOR / CONSORT提案)。与保守治疗老年患者远端radius骨复杂的关节内骨折相比,ORCHID是首个旨在评估手术治疗后生活质量和功能结局的多中心RCT。预期结果将影响国际上未来的治疗建议和政策。试用注册ISRCTN:ISRCTN76120052注册日期:2008年7月31日;首例患者的随机分组:15.09.2008

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号